Harshil Agrotech Reports 433% Net Profit Growth Amid High Management Efficiency

Dec 23 2024 06:40 PM IST
share
Share Via
Harshil Agrotech has recently seen a revision in its score by MarketsMojo, reflecting the company's strong management efficiency and impressive net profit growth. Despite a mildly bearish market position and technical challenges, the stock remains attractive due to its solid performance indicators and significant returns over the past year. In a recent update, Harshil Agrotech's stock evaluation was adjusted by MarketsMojo, which now categorizes it as a 'Hold.' This decision comes on the heels of the company's remarkable return on equity and substantial net profit growth of over 400% in its latest financial results. The firm reported net sales of Rs 35.42 crore in the first half of the year, alongside a record PBDIT of Rs 4.99 crore for the quarter. While the stock is currently experiencing a mildly bearish trend influenced by technical factors, it is trading at a discount compared to historical averages, despite a relatively high price-to-book ratio. Over the past year, Harshil Agrotech has delivered a commendable return, with profits increasing significantly, indicating a positive trajectory for the company amidst a challenging market environment.
Harshil Agrotech, a microcap player in the trading industry, has recently reported impressive financial metrics that highlight its strong market position. The company achieved a remarkable net profit growth of 433.33% in the quarter ending September 2024, showcasing its operational efficiency. This performance is underscored by a high return on equity (ROE) of 44.60%, indicating effective management and profitability.

In terms of sales, Harshil Agrotech reported net sales of Rs 35.42 crore for the half-year period, while its profit before depreciation, interest, and taxes (PBDIT) reached a record Rs 4.99 crore in the latest quarter. The company has consistently delivered positive results over the last three quarters, reflecting its robust financial health.

Despite these achievements, the stock is currently positioned in a mildly bearish range, influenced by various technical indicators. However, it has demonstrated consistent returns over the past three years, outperforming the BSE 500 index in each of those periods. With a price-to-book value of 4.1, the stock is considered to have a high valuation relative to its historical averages, even as it trades at a discount compared to its past performance.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News